• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克隆性IGH重排的下一代测序检测原位滤泡性肿瘤中正在进行的突变和滤泡间游走。

Next generation sequencing of the clonal IGH rearrangement detects ongoing mutations and interfollicular trafficking in in situ follicular neoplasia.

作者信息

Kosmidis Perikles, Bonzheim Irina, Dufke Claudia, Colak Sema, Hentrich Thomas, Schroeder Christopher, Bauer Peter, Adam Patrick, Fend Falko

机构信息

Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany.

Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany.

出版信息

PLoS One. 2017 Jun 22;12(6):e0178503. doi: 10.1371/journal.pone.0178503. eCollection 2017.

DOI:10.1371/journal.pone.0178503
PMID:28640838
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5480878/
Abstract

Follicular lymphoma (FL) is characterized genetically by a significant intraclonal diversity of rearranged immunoglobulin heavy chain (IGH) genes and a substantial cell migration activity (follicular trafficking). Recently, in situ follicular neoplasia (ISFN), characterized by accumulations of immunohistochemically strongly BCL2-positive, t(14;18)+ clonal B cells confined to germinal centers in reactive lymph nodes, has been identified as a precursor lesion of FL with low risk of progression to manifest FL. The extent of ongoing somatic hypermutation of rearranged IGH genes and interfollicular trafficking in ISFN is not known. In this study we performed an in depth analysis of clonal evolution and cell migration patterns in a case of pure ISFN involving multiple lymph nodes. Using laser microdissection and next generation sequencing (NGS) we documented significant intraclonal diversity of the rearranged IGH gene and extensive interfollicular migration between germinal centers of the same lymph node as well as between different lymph nodes. Furthermore, we identified N-glycosylation motifs characteristic for FL in the CDR3 region.

摘要

滤泡性淋巴瘤(FL)的遗传学特征是重排的免疫球蛋白重链(IGH)基因存在显著的克隆内多样性以及大量的细胞迁移活性(滤泡迁移)。最近,原位滤泡性肿瘤(ISFN)已被确定为FL的前驱病变,其进展为明显FL的风险较低,其特征是免疫组化显示BCL2强阳性、t(14;18)+克隆性B细胞聚集于反应性淋巴结的生发中心。ISFN中重排的IGH基因正在进行的体细胞超突变程度以及滤泡间迁移情况尚不清楚。在本研究中,我们对一例累及多个淋巴结的纯ISFN病例的克隆进化和细胞迁移模式进行了深入分析。通过激光显微切割和下一代测序(NGS),我们记录了重排的IGH基因显著的克隆内多样性以及同一淋巴结生发中心之间以及不同淋巴结之间广泛的滤泡间迁移。此外,我们在互补决定区3(CDR3)区域鉴定出了FL特有的N-糖基化基序。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b828/5480878/262ca3a41db1/pone.0178503.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b828/5480878/005ff8ea5839/pone.0178503.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b828/5480878/741293ea49e3/pone.0178503.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b828/5480878/1b057ed8974d/pone.0178503.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b828/5480878/262ca3a41db1/pone.0178503.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b828/5480878/005ff8ea5839/pone.0178503.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b828/5480878/741293ea49e3/pone.0178503.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b828/5480878/1b057ed8974d/pone.0178503.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b828/5480878/262ca3a41db1/pone.0178503.g004.jpg

相似文献

1
Next generation sequencing of the clonal IGH rearrangement detects ongoing mutations and interfollicular trafficking in in situ follicular neoplasia.克隆性IGH重排的下一代测序检测原位滤泡性肿瘤中正在进行的突变和滤泡间游走。
PLoS One. 2017 Jun 22;12(6):e0178503. doi: 10.1371/journal.pone.0178503. eCollection 2017.
2
In situ analysis of the variable heavy chain gene of an IgM/IgG-expressing follicular lymphoma: evidence for interfollicular trafficking of tumor cells.表达IgM/IgG的滤泡性淋巴瘤可变重链基因的原位分析:肿瘤细胞滤泡间迁移的证据
Am J Pathol. 2002 Mar;160(3):883-91. doi: 10.1016/S0002-9440(10)64911-5.
3
Cell migration patterns and ongoing somatic mutations in the progression of follicular lymphoma.滤泡性淋巴瘤进展过程中的细胞迁移模式及持续的体细胞突变
Cytogenet Genome Res. 2007;118(2-4):328-36. doi: 10.1159/000108317.
4
Widespread in situ follicular neoplasia in patients who subsequently developed follicular lymphoma.广泛原位滤泡性肿瘤患者随后发展为滤泡性淋巴瘤。
J Pathol. 2022 Apr;256(4):369-377. doi: 10.1002/path.5861. Epub 2022 Mar 3.
5
Transformation of follicular lymphoma to plasmablastic lymphoma with c-myc gene rearrangement.滤泡性淋巴瘤向具有 c-myc 基因重排的浆母细胞淋巴瘤的转化。
Am J Clin Pathol. 2010 Dec;134(6):972-81. doi: 10.1309/AJCPWY1SGJ9IEAOR.
6
Grade I, II and III Follicular Lymphomas Express Ig V Genes with Different Patterns of Somatic Mutation.I 级、II 级和 III 级滤泡性淋巴瘤表达具有不同体细胞突变模式的 Ig V 基因。
Pathol Oncol Res. 2020 Oct;26(4):2765-2772. doi: 10.1007/s12253-020-00843-x. Epub 2020 Jul 23.
7
Incidence, clinicopathological features and genetics of in-situ follicular neoplasia: a comprehensive screening study in a Japanese cohort.原位滤泡性肿瘤的发病率、临床病理特征和遗传学:一项日本队列的综合筛查研究。
Histopathology. 2022 Apr;80(5):820-826. doi: 10.1111/his.14617. Epub 2022 Feb 22.
8
Detection of t(14;18) by PCR of IgH/BCL2 fusion gene in follicular lymphoma from archived cytological smears.通过对存档细胞学涂片上滤泡性淋巴瘤进行IgH/BCL2融合基因的聚合酶链反应检测t(14;18)
Coll Antropol. 2010 Jun;34(2):425-9.
9
A retrospective study of patients with follicular lymphoma (FL): identification of in situ FL or FL-like B cells of uncertain significance in lymph nodes resected at the time of previous surgery for carcinomas.一项对滤泡性淋巴瘤(FL)患者的回顾性研究:在前次因癌症进行手术时切除的淋巴结中,原位FL或意义未明的FL样B细胞的鉴定。
J Clin Pathol. 2015 Jul;68(7):541-6. doi: 10.1136/jclinpath-2015-202933. Epub 2015 Apr 10.
10
Genetic evolution of follicular neoplasia to aggressive B-cell lymphoma of germinal center subtype.滤泡性腺瘤向生发中心 B 细胞淋巴瘤侵袭性亚型的遗传进化。
Haematologica. 2021 Oct 1;106(10):2673-2681. doi: 10.3324/haematol.2020.254854.

引用本文的文献

1
Follicular Lymphoma in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms-Updated Classification and New Biological Data.《世界卫生组织血液淋巴系统肿瘤分类第5版:滤泡性淋巴瘤——更新的分类与新的生物学数据》
Cancers (Basel). 2023 Jan 27;15(3):785. doi: 10.3390/cancers15030785.
2
Next-generation sequencing for MRD monitoring in B-lineage malignancies: from bench to bedside.用于B系恶性肿瘤微小残留病监测的下一代测序:从实验室到临床
Exp Hematol Oncol. 2022 Sep 3;11(1):50. doi: 10.1186/s40164-022-00300-2.
3
Characterization of the Intra-tumoral B Cell Immunoglobulin Repertoire Is of Prognostic Value for Esophageal Squamous Cell Carcinoma.

本文引用的文献

1
Lectins from opportunistic bacteria interact with acquired variable-region glycans of surface immunoglobulin in follicular lymphoma.来自机会致病菌的凝集素与滤泡性淋巴瘤中表面免疫球蛋白的获得性可变区聚糖相互作用。
Blood. 2015 May 21;125(21):3287-96. doi: 10.1182/blood-2014-11-609404. Epub 2015 Mar 17.
2
Contiguous follicular lymphoma and follicular lymphoma in situ harboring N-glycosylated sites.伴有N-糖基化位点的连续性滤泡性淋巴瘤和原位滤泡性淋巴瘤。
Haematologica. 2015 Apr;100(4):e155-7. doi: 10.3324/haematol.2014.115782. Epub 2014 Dec 19.
3
Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression.
肿瘤内 B 细胞免疫球蛋白谱的特征对食管鳞状细胞癌具有预后价值。
Front Immunol. 2022 Jun 22;13:896627. doi: 10.3389/fimmu.2022.896627. eCollection 2022.
4
Widespread in situ follicular neoplasia in patients who subsequently developed follicular lymphoma.广泛原位滤泡性肿瘤患者随后发展为滤泡性淋巴瘤。
J Pathol. 2022 Apr;256(4):369-377. doi: 10.1002/path.5861. Epub 2022 Mar 3.
5
Follicular lymphoma: updates for pathologists.滤泡性淋巴瘤:给病理学家的最新资讯
J Pathol Transl Med. 2022 Jan;56(1):1-15. doi: 10.4132/jptm.2021.09.29. Epub 2021 Dec 27.
6
Follicular lymphoma subgroups with and without t(14;18) differ in their N-glycosylation pattern and IGHV usage.滤泡性淋巴瘤伴和不伴 t(14;18)的亚组在其 N-糖基化模式和 IGHV 使用上存在差异。
Blood Adv. 2021 Dec 14;5(23):4890-4900. doi: 10.1182/bloodadvances.2021005081.
7
Genetic evolution of follicular neoplasia to aggressive B-cell lymphoma of germinal center subtype.滤泡性腺瘤向生发中心 B 细胞淋巴瘤侵袭性亚型的遗传进化。
Haematologica. 2021 Oct 1;106(10):2673-2681. doi: 10.3324/haematol.2020.254854.
8
Lack of activation-induced cytidine deaminase expression in in situ follicular neoplasia.原位滤泡性肿瘤中缺乏活化诱导的胞苷脱氨酶表达。
Haematologica. 2021 Apr 1;106(4):1212-1215. doi: 10.3324/haematol.2020.249342.
9
IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications.IGHV 突变状态通过 NGS 揭示了具有不同预后意义的结外边缘区淋巴瘤的不同发病途径。
Virchows Arch. 2020 Jul;477(1):143-150. doi: 10.1007/s00428-019-02712-8. Epub 2019 Dec 4.
10
Clonally related duodenal-type follicular lymphoma and follicular neoplasia.克隆相关的十二指肠型滤泡性淋巴瘤和滤泡性肿瘤。
Haematologica. 2019 Nov;104(11):e537-e539. doi: 10.3324/haematol.2019.226142. Epub 2019 Aug 1.
过表达BCL2的B细胞生发中心再进入驱动滤泡性淋巴瘤进展。
J Clin Invest. 2014 Dec;124(12):5337-51. doi: 10.1172/JCI72415. Epub 2014 Nov 10.
4
t(14;18) Translocation: A predictive blood biomarker for follicular lymphoma.t(14;18) 易位:滤泡性淋巴瘤的一种有预测作用的血液生物标志物。
J Clin Oncol. 2014 May 1;32(13):1347-55. doi: 10.1200/JCO.2013.52.8190. Epub 2014 Mar 31.
5
Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma.在原位到表现为 t(14;18)阳性滤泡性淋巴瘤的克隆进化中,基因组和表观基因组复杂性增加。
Leukemia. 2014 May;28(5):1103-12. doi: 10.1038/leu.2013.307. Epub 2013 Oct 23.
6
Comparison of clinical targeted next-generation sequence data from formalin-fixed and fresh-frozen tissue specimens.比较福尔马林固定石蜡包埋和新鲜冰冻组织标本的临床靶向下一代测序数据。
J Mol Diagn. 2013 Sep;15(5):623-33. doi: 10.1016/j.jmoldx.2013.05.004. Epub 2013 Jun 26.
7
The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-"negative" grade 1/2 follicular lymphomas.BCL2 E17 和 SP66 抗体可区分 2 个免疫表型和遗传上不同的常规 BCL2-“阴性”1/2 级滤泡性淋巴瘤亚群。
Hum Pathol. 2013 Sep;44(9):1817-26. doi: 10.1016/j.humpath.2013.02.004. Epub 2013 May 2.
8
Somatic hypermutation analysis in follicular lymphoma provides evidence suggesting bidirectional cell migration between lymph node and bone marrow during disease progression and relapse.滤泡性淋巴瘤的体细胞超突变分析提供的证据表明,在疾病进展和复发过程中,淋巴结和骨髓之间存在双向细胞迁移。
Haematologica. 2013 Sep;98(9):1433-41. doi: 10.3324/haematol.2012.074252. Epub 2013 Apr 12.
9
Follicular lymphoma and the immune system: from pathogenesis to antibody therapy.滤泡性淋巴瘤与免疫系统:从发病机制到抗体治疗。
Blood. 2012 Apr 19;119(16):3659-67. doi: 10.1182/blood-2011-11-367730. Epub 2012 Feb 15.
10
Early steps of follicular lymphoma pathogenesis.滤泡性淋巴瘤发病机制的早期步骤。
Adv Immunol. 2011;111:1-46. doi: 10.1016/B978-0-12-385991-4.00001-5.